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CLINICAL STUDIES IN SULPHDNAMIDE CHEMOTHERAPY,
VOLUME 3 .
THE TOXIC EFFECTS OF THE SULP HON AMIDE DRUGS.
VOLUME 3,
VOLUME 3,
Chapter I .  Introduction. pp. 258- 260.
Chapter I I .  The Incidence of Toxic Effects. pp. 261-271*
The toxic effects are discussed under five main headings.
* «■
(a) Cyanosis. A general incidence of ten per cent, is  noted.
The rate varies with the different drugs and seems highest with 
sulphanilamide, possibly because of the number of cases which 
received a high preliminary dosage,and, in general, of the longer 
duration of treatment.
(b) Disturbances of the Central Nervous System. A general 
incidence of just under two per cent, is  noted. This includes a few 
cases of violent delirium for which the drugs seem to have been 
responsible.
(c) Pisturbances of the Gastrointestinal Tract. These are noted 
in less than eight per cent, of a ll the cases. With sulphapyridine 
this form of toxic effect is  not only more common bit more severe.
(d) Disturbances of the Urinary System. Haematurla or ureteric 
colic is  noted in less than one per cent, of cases which receive 
sulphapyridine. No case receiving the other drugs has developed such 
a toxic reaction.
(e) The Occurrence of Toxic Rashes and of Fever. These occur in 
just less than four per cent, of a ll the cases. Charts are appended
which show that individuals who develop rash and fever may show an 
allergic type of reaction to a single dose of the drug administered after 
a short lapse o f time.
Chapter I I I .  An Examination of the relation between
certain characteristics end the occurrence 
of toxic’effects. pp. 272- 276.
I t  is  shown that toxic reactions (excluding cyanosis) are less  
frequent in children under ten years of age. They are seen with 
greater frequency in females than in males. In the patients 
with erysipelas who show a toxic reaction, the lesion may cease to 
spread rather more slowly; the primary pyrexia, however, is  
definitely prolonged.
\
Chapter IV. Discussion. pp. 277- 284.
None of the toxic effects noted is  serious or causes harm
to the patients. The most interesting and important of the toxic
reactions is  the occurrence of a rash or of fever. A parallel
i s  drawn between 11 serum disease” and these drug rashes and drug
fever. I t  is  suggested, on the basis of the clinical findings
and after discussion of experimental work, that the sensitization






I do not intend to attempt a review of the literature that has 
been written on this subject. My reason for not so doing is  because 
such reviews convey a quite false impression of the dangers of the 
drugs. Few writers who report an unusual or serious side effect, 
include any details which would permit one to estimate how frequently 
such an event might occur. ( I t  is  as i f  someone reported that fifty  
fatal accidents had been noted at a certain crossing. The occurrence 
of such a large number (perhaps in one year) might cause one to use 
that crossing with caution, but i t  is  exceedingly important to know 
whether five hundred or five thousand persons used the crossing in 
that period). As the present report w ill reveal, the toxic effects 
of this useful group of drugs have been greatly over-emphasised.
Further, i t  might be suggested that the consultant physician or
surgeon called in, as he often is , to the unusual case, may see so 
many '’accidents” that he too tends to exaggerate their importance, 
forgetting that many other patients have received the drugs without 
untoward reaction.
In addition to those cases which have been described in the 
present report, I have been responsible for the management of many 
different types of infection for which sulphonamides have been prescribed. 
Since the records of the present cases were closed I have treated a
further 500 cases of erysipelas and as many cases of pneumonia. In
addition, the drugs have been used in some four to five hundred cases 
of meningococcal meningitis; while the effect of the drugs has been /
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been tested in cases of scarlet fever, measles, whooping cough, pneumonia 
in infants, typhoid, paratyphoid, the dysenteries, and smaller numbers 
of cases of septicaemia, septic sore throat and puerperal infection. 
Although i t  is  d ifficu lt to estimate the correct total number, at 
least 6,000 cases of different infections, in a ll age groups, have 
received sulphonamides under my direct supervision. Such a large series 
of cases permits one to be somewhat dogmatic regarding the occurrence 
of the different side-effects.
In the following analysis I shall describe the toxic effects 
which were noted in the series of erysipelas and pneumonia cases 
described in the preceding chapters. Since these records were closed,
I have seen only two forms of toxic reaction which were not encountered 
among the present series, namely, one case of acute granulocytopenia 
and one case of acute haeraolytic anaemia.
Three features which are common to a ll my cases may firs t  be 
mentioned. These are —
1. AL1 received their sulphonamides while at rest in bed.
2. Practically a ll started therapy with a polymorphonuclear
leucocyto si s.
3 . „ As part of the general nursing treatment of fever patients,
fluids were administered lavishly. As a rule, the quantity
of bland fluid consumed daily by a person over 15 years 
of age was from four to six pints.
These three common factors are, I am sure, important, and they may 
go far to explain the relative absence of serious toxic reactions in my 
experience. In regard to the first , the incidence of toxic reactions 
in cases of gonorrhoea (which are nearly always treated ambulantly) seems 
to be much higher than in pneumonia or erysipelas (McGregor Robertson; /
/(McGregor Robertson; personal communication). ' Second, French (1939) has 
reported a depressant effect of the sulphonamides upon the neutrophil 
cells of the blood. However, using .the drugs in fu ll dosage over a 
prolonged period in cases of scarlet fever, where a primary 
polymorphonuclear leucocytosis was always present, at no time was the 
fa l l  in neutrophil cells such as to cause anxiety. Logically, i t  would 
seem natural that the case which begins therapy when his blood contains 
a high proportion of these cells, is  in better shape to withstand 
the depressant effect of the drugs upon his bone marrow. Thirdly, 
i t  has already been explained that the largest proportion of the drugs 
is  excreted through the kidneys. The vaiying solubility of the 
different sulphonamides, and the fact that a proportion is  excreted 
in the acetylated form (as a rule, even less soluble than the parent 
drug) both emphasise' the importance of a high urinary output.
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„  *
I t  is  not, of course, implied that the presence of a leucopenia
at the onset of treatment is  necessarily dangerous. I  have observed 
cases of pneumonia in which the white cell count was as low as 
3*000 per c*mm. in itia lly , and where the number o f cells gradually 
increased during the period of administration of sulphonamide drugs.
CHAPTER II .
The Incidence of Toxic Effects.
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The toxic effects noted in the present series of cases may be 
summarised under the folio wing headings:-
(a) Cyanosis.
(b) Disturbance of the Central Nervous System.
(c) Disturbance of the Gastrointestinal Tract.
(d) Disturbance of the Urinary System.
(e) The occurrence of rashes or of unexplained pyrexia.
t
( a) Cyano si s.
The unusual colour which developed in patients receiving 
sulphonamides was the firs t  noticeable feature caused by the drugs.
In cases of erysipelas, even before frank cyanosis was noted, i t  was
/
found that the lesion ^stood out" more obviously in those cases which 
received the drugs; the line of demarcation between inflamed and healthy
skin was much more intense. I am inclined to think that this was an
early grade of cyanosis which was more obvious in the engorged plaque 
of inflammation. The presence of generalised cyanosis was usually
f
easily noticed, since i t  gave the patient an unnaturally " i l l "  appearance. 
This was often worrying in the early days, not only to the patient* s 
relatives but to the nursing staff and myself. In these earlier
patients treatment was frequently stopped when cyanosis of any 
intensity developed; but, as experience with the drugs increased, even
severe degrees of .cyanosis were discounted and therapy continued. The /
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The figures which follow therefore.must be regarded as referring to 
those patients whose degree of cyanosis gave rise to comment. The 
presence of a slight cyanotic tinge was often not noted, especially in 
the later stages of the experiment, since its  occurrence seemed in no 
way to upset the patient.
The incidence of cyanosis with the different drugs used was 
as follows:-
Drug. No. of Cases 
treated.
No. of Cases 
showing cyanoi
Sulphonamido-chrysoidin 381 17  ( 4. 5)
Sulphanil amide 3 7 , 1 0 5 .(34.3 )
Ben zyl-sulphonamide 70 5 ( 7.1 )
Carboxy-sulphonamido- 
chrysoidin 89 1 (1 . 1 )
Sulp hapy ri din e 481 5 (1.04)
Total;- 1333 133 (10 . 0)
(The figures in brackets are percentages of the total 
cases in the group).
It  is  clear that the incidence of cyanosis varies considerably 
with the different drugs, being highest with the radicle sulphanilamide 
(34 per cent.) and lowest with sulphapyridine (1.0 per cent.). I t  is  
difficu lt to explain this variation. Cyanosis may be due to the
development of methaemoglobih or sulphaemogLobin. In some cases, 
however, which show clinical cyanosis, these two pigments cannot be 
definedj this undefined pigment may be formed by the drugs themselves 
(Marshall and Walzl, 1937).
Although /
Although, in the earlier stages, a number of spectroscopic examinations 
of the blood was made upon suspicious cases, in only two was the presence 
of sulphaemoglohinaemia proved. Two other cases (not examined 
spectroscopically) were suspected later in the experiment on account 
of the severity and prolonged duration of the cyanosis. All four received 
sulphanil amide.
During one stage of the experiment precise enquiry was made as to 
whether the patient had or had not taken a sulphate purgative within 
forty-eight hours of admission. Seventy (29 per cent.) of 242 patients 
gave such a history. The incidence of cyanosis in this group was 32.8 
per cent., whereas in those who had not taken a saline purgative the 
incidence was 29 per cent. In no case did the intensity of the cyanosis 
suggest a sulphaemoglobinaemia.
There seems l i t t l e  doubt that in some cases (Paton and Eaton, 1937> Archer<B 
Discombe, 1937) there is  a causal relation between premedication with 
saline purgatives and the occurrence o f sulphaemoglobinaemia; and i t  has 
been suggested that the f lu id ity  o f the contents o f the large bowel is  
the factor o f e tio log ica l importance. Cyanosis o f a degree to suggest 
sulphaemoglobin has only been noted by me on, at the most, four occasions.
The rarity of its  occurrence might suggest that the peculiarity which 
causes its  formation lie s  in the patient. Although, to begin with, great 
care was taken to exclude such articles as eggs and onions from the 
diet (since they contain small amounts of sulphur), in later periods no 
such precautions were enforced; and the incidence of severe grades of 
cyanosis did not appear to be affected.
The /
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The following case history, however, does suggest that in some 
persons at least, sulphur-containing preparations may be dangerous.
"A ward maid, 19 years of age, was seen late on her first  day of 
illness with an inflammatory area over the pre-patellar bursa. There 
was a small laceration overlying the bursa. The condition was diagnosed 
as a septic pre-patellar bursitis and she was admitted to the 
erysipelas ward. She had been given a dose of magnesium sulphate by 
mouth, and when admitted to the ward, as the case was not' regarded as 
an erysipelas, dressings of glycerine and magnesium sulphate were 
applied. On the following morning, unaware of the type of dressing 
which was being applied, I re-examined the knee and found that the 
condition was in fact an erysipelas. Spread had taken place since 
the earlier examination and the raised border was now very definite.
She was accordingly entered into the erysipelas series and was given 
sulphanilamide. During the next eighteen hours she received a
total of 9.0 grams of the drug, when her condition suddenly became 
alarming. An intense violet cyanosis appeared, overlying what 
appeared to be an ashen pallor. The pulse rate rose rapidly to 120 
and was of poor quality. The respirations were sighing and shallow. 
Examination of the blood by the spectro-microscope revealed the 
presence of sulphaemoglobin. For the next 24 hours her appearance 
was somewhat alarming but thereafter she slowly recovered, although
the cyanosis was s t i l l  evident for about four weeks. There seemed 
l i t t le  doubt that in this case the sulphaemoglobinaemia was related 
to the use of a saline purgative and possibly also to the local 
dressings which contained magnesium sulphate."
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(b) Disturbaiices of the Central Nervous System.
Another early observation made in the erysipelas cases suggested 
that the sulphonamides had a depressant effect upon the nervous system. 
Quite frequently when the morning visit was being paid i t  would be 
found that the patients receiving sulphonamide drugs were s t i l l  
asleep, or dosing. Some, on awaking, seemed slightly confused or 
disorientated. Enquiry among the more intelligent patients often 
elicited the information that the drugs made them feel "dizzy M and 
unable to concentrate. In a few cases, the patient exhibited a sudden 
delirium, not accounted for by the severity of his illness.
"A female, 58 years of age, had received sulphonamido-chrysoidin 
during the acute stage and early convalescence of a recurrent attack 
of facial erysipelas. Upon the twelfth day of illness (nine days 
after admission) she was noted to have a severe shivering. After this 
she became very noisy, tore her spectacles from her face, broke them . 
and threw them at her neighbour. She was very abusive to the nursing 
staff for a short time (surprising, because she had previously appeared 
a very mild-tempered woman) • Just as suddenly she subsided, fe ll  
asleep, and on waking, had no recollection of the occurrence. "
A similar type of reaction was noted in a male who suddenly jumped 
out of bed, seized a siphon which whs on his locker, flung i t  through 
a nearby window and then attempted to follow it .
In neither of these cases did the delirium seem to be explained 
by the erysipelas, the healing of which was in fact well advanced; nor 
by a history of alcoholism. The sulphonanide drugs seemed to be the
only reasonable explanation.
Including /
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Including a ll varieties of disturbance from severe drowsiness 
or dizziness to mental confusion or delirium, the incidence with 
the different drags was as follows:-
Drug. Total No, Total showing
of Cases. mental disturb-
ances.
Sulphon amido-chrysoidin 331 11 (2.9)
Sulphanilamide 317 10 ( 3 .1)
Benzyl-sulphon amide 70 0 ( 0 )
Carboxy-sulphonamido-chrysoidin 89 4 (4.5)
Sulphapyridine 481 1' (0. 2)
Total:- 1338 26 (1.9)
(The figures in brackets are percentages of the 
different totals).
There is  l i t t le  actual difference here between any of the drugs. 
The standard error of difference between the highest incidence (4.5 
per cent.) and that for a ll cases (1.9 per cent.) is  12.24, so that 
the difference is  not significant. The rate for sulphapyridine, 
however, seems surprisingly low.
(c) Disturbances of the Gastrointestinal Tract. 1
The commonest toxic effects noted were nausea, vomiting, 
epigastric pain and diarrhoea. The incidence ,of these in patients 
receiving the different drugs was as follows:-
Drug. Total Cases Total showing
Treated. Toxic E ffects.
Sulp hon ami do- chry soi din 331 26 ( 6. 8)
Sulphanilami de 317 10 (3-2)
Ben zy l- sulphon amide 70 1 (1.4)
Carboxy-sulphon amido-chrysoidin 89 3 (2.4)
Sulp hapy r i  din e 481 60 (12.4)
Tota l:- 1338 100 (7 .5 )
( The figures in brackets are percentages of the different totals).
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I t  is  clear that sulphapyridine is not the only sulphonamide 
which can give rise to gastrointestinal upset. It  should, however, 
be made clear that the symptoms with this drug are much more intense 
than with the other four. Many patients reached a stage when they 
refused to accept another dose of sulphapyridine; this situation was 
never encountered with the other drugs.
(d) Disturbances of the Urinary System.
No case of erysipelas was encountered where there was any apparent 
damage to the urinary tract from the drugs given. In fact, the drugs 
were given, without i l l  effect, to patients who showed an acute 
nephritis on admission to hospital. In four cases of pneumonia that
received sulphapyridine, however, such a disturbance was noted. In
three cases haenaturia was found and in the fourth there was a 
complaint of pain —  in site and nature very suggestive of ureteric 
colic. In this last case no haematuria was noted although the urine 
v?as repeatedly examined microscopically. The incidence is  thus O.83 
per cent. In each of these cases the patient had been unco-operative 
and his fluid intake had been unsatisfactory.
It  is  clear that the solubility of the drug is  here a factor of 
great importance. Although many urines were examined, the earlier 
drugs were always dissolved in the urine as passed; but with 
sulphapyridine, when the urine cooled, crystals v/ere often easily seen 
under the microscope.
With sulphon ami do- chry soi din the urine (and the faeces) was always 
coloured a bright brick red. This caused a very "fast" staining of the
bed-linen but seemed to have no effect upon the patient. Curiously, with
the other red dye, carboxy-sulphonanido-chrysoidin, the urine was not 
coloured.
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(e ) The Occurrence o f Toxic Rashes and o f Fever.
The incidence o f these conditions with the f iv e  drugs used is  
shown in Table-1.
TABLE 1.

















Sulp hon ami do- chry soi din 7 ( 1 -8 ) 7 (1 .8) 14 (3-7) 38I
Sulphanilamide 6 ( I . ? ) 15 (4.7) 21 (6.6) 517
B en zyl- sulp hanil ami de 2 (2.8) 2 (2.8) 4 (5-7) 70
Carbo xy- sulp hon ami do-chry soi din 1 ( l . l ) 0 ( 0 ) 1 ( l . l ) 89
Sulp hapy ri di n e 7 (1-5) 2 (0.4) 9 (1*9) 431
Totals- 23 (I*  7) 26 (1 .9) 49 (3-7) 132$
(The figures in brackets are percentages o f the tota l in the group).
Rashes. The usual rash noted closely resembled that o f rubella. 
The elements o f the rash consisted o f rather small, maculo-papules 
which tended to coalesce. The colour was a bright pink. In the 
majority o f cases the skin was very ir r ita b le . The rash, as a rule, 
appeared a fter treatment had continued fo r some 7-12 days. The 
distribution o f the rash was very variable. In some .cases i t  was 
generalised and profuse; in others the rash was confined to certain
areas; As a rule, the extensor aspects were particu larly involved, the 
elbows and knees being rarely spared. The back o f the trunk, the /
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the flenks and buttocks usually showed a profuse cropping. The rash 
was often noted on the face and when this occurred the circunoral 
region was not spared, fin a lly , i t  was not infrequent to find slight 
oedema and redness o f the eyelids; pinkness o f the conjunctivae served 
to complete the close resemblance to rubella. A certain amount o f 
fe b r ile  disturbance usuelly accompanied the eruption. The temperature 
as a rule did not exceed 99° or 100° Fahrenheit, but in some esses 
high fever up to 103° Fahrenheit was noted.
Fever. When the results obtained with d ifferen t dosage o f  the 
drugs in erysipelas were reported, I  advanced the suggestion that the 
primary fever might be prolonged when large doses were administered.
I  am in no doubt that one occasionally sees this prolongation o f primary
pyrexia as a d irect toxic e ffec t. Sometimes, in cases o f 
meningococcal meningitis, fever has continued despite the fact that 
the physical signs and examination o f the cerebrospinal flu id  indicated 
that the in fection was under control. The decision to stop the drug 
in  such cases is  sometimes reached with d iff ic u lty . Much more 
frequently, however, this toxic e ffec t makes i t s  appearance when the 
primary pyrexia has ceased and a fter an in terval o f normal temperature 
o f from three to f iv e  days; that is , on the f i f t h  to tenth day 
o f treatment. In these cases no rash is  to be seen, end when 
administration o f the drug is  stopped the fever subsides fa ir ly  rapidly.
The causation o f these two conditions, namely, la te  rashes and 
la te  fever, seem to me to be related. The temperature charts shovn 
in  Figures 1 ana 2 (which could be repeated by many others) may supply 
a clue to their orig in . I t  w ill be seen that the administration o f a /
Explanatory Legend to Pig. 1.
This patient was admitted to hospital as a case of 
measles. On admission, Rubella was suspected; bit a history 
was obtained that sulphapyridine had been administered for 
several days prior to admission. As the chart shows, the 
subsequent administration of a single dose of 0 . 5 6®* of this 
drug was responsible for a very acute reaction characterised 
by high temperature, shivering, headache, suffused eyes and a 
bright generalised morbilliform rash.

Explanatory Legend to Fig. 2.
This patient v~as admitted as a case of pneumonia in his 5th 
day of illness; the diagnosis was confimed. Sulphadiazine vas 
given bit although the consolidation did not spread and no 
complication was noted, the pyrexia continued and the patient 
remained toxic. On the eighth day of treatment the appearance 
of a typical drug rash suggested the cause of the continued fever: 
stoppage of the drug caused a rapid subsidence of the fever. later, 
a single dose of the drug produced a typical sensitisation reaction.
The chart is  an excellent illustration of the continuation of 

















































































































-  270 -
a single dose of the drug at a later date has induced an immediate 
repetition of the earlier toxic signs. This finding suggests that rash 
and fever are due to sensitisation. I t  has been suggested that photo­
sensitisation is  a factor in the causation of drug rashes (Erskine, 1942; 
Park and Platts, 1942) f that they show a tendency to be most 
profuse on parts of the body commonly exposed to sunlight. In my own 
series of cases this has not occurred, and as I have stated above, the 
rash was usually most profuse on the elbows and knees, the buttocks 
and flanks. Further, i t  should not be forgotten that 49 cases of 
erysipelas received combined treatment with sulphonamido-chrysoidin and 
ultra-violet light from a mercury vapour lamp (Snodgrass and Anderson, 1937)
Although several doses of artific ia l sunlight were given to many of the 
%
cases, not a single one developed any kind of rash — either local 
or general.
From the figures given in Table 1, i t  is  dear that the incidence 
of both rashes and fever varies l i t t le  with different drugs of the
sulphonamide series. In regard to the occurrence of rashes, the figures 
show a dose resemblance varying from 1 .1  per cent, to 2.8 per cent., with 
a mean for the whole series of 1.7 per cent. In regard to the occurrence 
of fever, there is  rather more disagreement. For a ll but sulp hanil amide 
the figures may be regarded as essentially similar. The difference 
between the incidence per cent, for sulphanilamide and tha.t for the
whole series ( 2.8 per cent.) has a standard error of + 1.25* I f  a 
difference greater than twice the standard error is  accepted as significant, 
then ndrug fever” is  more frequent in patients who receive sulphanilamide.
As a possible explanation of this may be advanced the fact that in
/
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in stages 2 and 3 o f  the experiments upon erysipelas, sulphanil amide
4
was frequently administered in what I would now regard as an 
excessive dose, namely, 2,0 grams four-hourly during the acute stage, 
finally, in comparing the figures obtained with the four drugs as 
used in the treatment of erysipelas, and sulphapyridine as used in the 
treatment of pneumonia, i t  should be remembered that with the latter 
the treatment period was slightly shorter. In the case of pneumonia, 
i t  was unusual for treatment to extend beyond the seventh day in 
hospital, whereas in erysipelas (with the exception of the firs t  stage 
of the experiment), treatment was often continued until the 
fourteenth or fifteenth day.
Summary.
A survey of 1,33$ cases that received a sulphonamide drug shows 
that a wide variety of toxic effects occurred. No case showed 
serious toxicity, although in two patients who developed sulphaemo- 
globinaemia the clinical appearance in itia lly  was somewhat alarming. 
The appearance of a rash or fever formed the most interesting group
of toxic reactions. Charts are shown which suggest that these 
effects may be of the nature of a sensitisation to the drugs.
CHAPTER I I I .
An Examination of the Relation between Certain 
Characteristics and the Occurrence of Toxic
Effects.
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In this analysis I shall confine myself to the study of the figures 
obtained with the three drugs mainly used, namely, sulphonamido-chrysoidin, 
sulphanilamide and sulphapyridine. Only with these three are the 
figures large enough to permit satisfactory deductions to be drawn.
(a) The Effect of Age upon the Occurrence of Toxic Effects.
TABLE 2.





S.C. S. A. S.P. All drugs.
Col. 1 Col. 2 Col.l Col. 2 Col.l Col. 2 Col.l Col. 2




11-40 137 24 103 15 280 44 520
41 + 219 26 135 20 201 28 555 74
(13.4)
381 51 317 41 481 62 1179 164
(13-9)
Note: Col. 1 -  Total cases receiving that drug.
Col. 2 -  Actual number of toxic effects arising, 
cyano si s excluded.
S. C. = Sulphonamido-chrysoidin.
S. A. = Sulphanilamide.
S. P. = Sulphapyridine.
(The figures in brackets are percentages).
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The analysis in respect of age with the three drugs is  shown 
in Table 2. Cyanosis has been excluded because, although i t  must be 
regarded as a toxic effect of the drugs, its  appearance is  of such 
slight importance that i t  may usually be disregarded.
Study of Table 2 draws attention in accurate figures to the low 
incidence of toxic effects in the young, for the incidence is  only 
a half of that noted in the adult. This low rate seems to be 
associated only with childhood, for the rates for those between 11 
years and 40 years and those over the age of 40 are essentially 
similar for a ll the drugs. This is  a point of some importance. In 
some infections, for example, erysipelas and meningococcal meningitis, 
the severity is  greater in young children. I t  is  satisfactory to know 
that the drugs may perhaps be used with greater freedom in this period 
of l i fe .  The cause of the difference is  not easy to explain. The 
f irs t  point of importance may be that, relatively, children absorb much 
more fluid than adults. I have already stated my belief in the 
importance of a high fluid intake. In the very young children who 
formed the bulk of the erysipelas patients under the age of 10 years, 
the diet was, naturally, almost entirely fluid. I t  would further seem 
natural that, in.young children, the excretory apparatus is  unlikely 
to show even the slight degenerative changes that may appear as age 
advances. I f  this were the whole explanation, however, one would expect 
the incidence of toxic reactions to increase with age. The similarity 
of the incidence above and below forty years would not support such 
a view.
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(b) The Effect of Sex upon the Occurrence of Toxic Effects,
The same set of figures is  subdivided into the tv/o sexes in 
Table 3*
TABLE 3 .
The Incidence of Toxic Effects with three 
drugs in the two sexes.
Sex
S. C. S. A. S.P . Com bin |sd drugs.
Col.l Col. 2 Col.l Col. 2 Col.l Col. 2 Col.l Col. 2
Male 187 17 168 13 330 38 685 68
(9.9)




381 51 317 41 481 75 1179 167
Note: S.C., S.A., and S.P. represent Sulphonamido-chrysoidin,
Sulphanilamide and Sulphapyridine, respectively.
Col.l — Total cases in treatment group.
Col.2 — Actual number of toxic effects, excluding cyanosis. 
(The figures in brackets are percentages).
Study of Table 3 shows that with each of the three drugs toxic effects
are more common in females than males. When the figures for the three 
drugs are combined, we find a difference in favour of males of 10.1 per
cent. The standard error is  12.14 which suggests that the difference is
significant. Even when one concentrates upon the occurrence of a rash or
fever (which I have already suggested may possibly be due to sensitisation)
the figures show a similar distribution. Forty-three patients showed
rash, fever or both combined; of these thirty-two occurred in females.
In other words, nearly 75 Per cent, of those who showed such toxic
reactions were females although just less than 42 per cent, of the total 
cases were of this sex.
I can offer no explanation for this surprising difference.
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(c) An Examination of the Results of Treatment obtained 
iDL cases which showed some toxic effect.
It  has occurred to me to be worth while to examine the results obtained 
in those cases which displayed some toxic reaction to the drug and to
compare them with the results which were given in the earlier part of this
report. In order to compare two groups as nearly alike as possible, I 
shall confine the analysis to those cases of erysipelas which received 
sulphon ami do-chry soi din or sulphanil amide. It  w ill be remembered that a 
comparison was made between the results of treatment obtained with ultra­
violet light and these same two drugs in the preliminary assessment of the 
results in erysipelas (see p. 41 ). These cases w ill now be used as the
control group for comparison. The relevant figures are shown in Table 4.
TABLE 4.
Duration, in days, of Spread and Primary Pyrexia in cases 




Duration, in days, t i l l  Cessation.
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*  In both cases the fever was prolonged by the drug:
Group A: Those cases treated in stages 1,2 and 4 (i .e . with
sulphonamido-chrysoidin or sulphanil amide) of the 
original experiment and already reported (p. 4.7 ).
Group B: Those cases from the whole series which received
sulphonamido-chrysoidin or sulphanilamide and which 
showed a toxic reaction, including cyanosis.
(The figures in brackets are percentages).
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Examination of Table 4 shows that of Group A, 90*3 Per cent, ceased 
to spread within twenty-four hours of admission; the equivalent 
figure for Group B was 84.5 per cent. The difference (5*8 per cent.) 
has a standard error of i  3*1^, so that i t  might have arisen by chance.
In Group A, 80.6  per cent, of the cases (excluding those apyrexial 
on admission) ceased to show fever after 48 hours in hospital; in 
Group B, the equivalent rate was per cent. The difference (9*9 
per cent.) has a standard error of 1 4.1 per cent., so that i t  may be 
regarded as outside the limits of chance variation.
It  would thus seen that the fa ll  in temperature may be slightly 
delayed in those cases which show a toxic reaction to the drug.
Such a finding adds point to the conclusion drawn from the use of 
the drugs in erysipelas, that prolongation of primary pyrexia may 
result from excessive dosage.
Summary.
The occurrence of a toxLc effect (other than cyanosis) due to 
the drug is  examined in relation to ( i )  the age, ( i i )  the sex and 
( i i i )  the rapidity of abatement of certain clinical characteristics.
I t  is  shown that toxic symptoms are less common in young children 
than in adults. This may be due to the larger relative intake of 
flu id in young children. ,Toxic symptoms are found to arise more
frequently in female than in male patients: no explanation can be
afforded for this finding. Finally, in cases of erysipelas, i t  is  
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Discussion.
The cases described represent the only toxic effects discovered 
in a series o f ’1,338 cases receiving some form of sulphonamide. With 
the exception of the early cases of sulphaemoglobinaemia, none gave 
rise to any anxiety. Indeed, cyanosis I would now regard as a 
natural accompaniment of sulphonamide therapy which should not permit 
any interference with the scheme of treatment. Once experience with 
the drugs had increased, I paid no attention to its  development and 
continued administration of the drug; often to find that, as treatment 
continued, cyanosis appeared to lessen.
Severe mental disturbance was so unusual that it ,  too, could well 
be overlooked, at least when the drugs were being given to a recumbent 
patient. I would advise that their occurrence, however, should induce 
care when the drugs are given to ambulant persons.
With sulphapyridine, vomiting was frequently a very distressing 
toxic effect. I found that no form of therapy reduced its  incidence. 
Further, i t  occurred in a case receiving the drug entirely by the 
intravenous route; such a finding suggests that the gastrointestinal 
disturbance might be of central origin. Haematuria occurred only with 
sulphapyridine and even then in but a handful of patients. Microscopic
examination of many specimens of urine from patients under treatment 
failed to reveal the presence of more than a few red bLood cells. It  
seems reasonable to suggest that the large quantities of fluid imbibed 
were responsible for the low incidence of this toxic effect.
The /
The occurrence of drug rashes and drug fever can be disturbing. 
Quite apart from the difficulty of diagnosis from measles or 
rubella (and in an infectious diseases hospital this may be important), 
i t  might have serious consequences i f ,  subsequently, the patient 
should require sulphonamides for a serious infection. I think i t  is  
worth stressing their relatively lower incidence with sulphapyridine 
and suggesting again that the reason is  the shorter duration of 
treatment. To review the case at the end of seven days with a view 
to terminating treatment would appear to be a wise rule.
The temperature charts which have been shown emphasise the 
feature of sensitisation. In my vieYir, after long experience of the 
administration of serums and antitoxins in different, diseases, the ‘ 
resenblance betv/een "serum disease” and these toxic effects with the 
sulphonamides is  very striking. The incubation period, for example, 
i s  similar, for in the "normal” type of serum reaction the duration 
between the injection of the foreign material and the appearance of 
the reaction is  about six to twelve days. One might in fact, with 
drug fever and drug rash, parallel fa irly  well the three classical 
forms of serum disease, the "normal”, the "accelerated” and the 
"immediate”. (Muir and Ritchie's Manual of Bacteriology, 10th ed., 1937)*
A. Normal. 1. Serum Disease: Here there is  no history of previous 
serum injection and the patient is  not spontaneously sensitive.
The incubation period is  from 6 - 1 2  days.
2. Drug reaction: The normal reaction of the
appearance of rash and/or fever about 9 - 1 2  days after the commencement
of administration of the drug fits  this description well.
B. /
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B. Accelerated. 1. Serum Disease: This form is  more common in 
persons who have had previous experience of antiserums* The 
incubation period is  shorter, from 2 - 5  days.
2. Drug reaction: This description might f it
the form of reaction which I have described as a prolongation of the 
normal pyrexia. One would imagine that the pyrexia of the original 
disease w ill account for the first  two days, so that the drug fever 
only dates from about the second or third day of treatment. It  
might be suggested that this w ill occur in persons who have had 
previous experience of the sulphon amide drugs or of chemicals 
containing similar groupings.
C. Immediate., 1. Serum disease: Here the reaction occurs 
instantaneously on the administration' of the foreign protein. This 
reaction undoubtedly occurs rarely end probably indicates either 
spontaneous sensitivity or previous sensitisation with a similar 
foreign protein.
2. Drug reaction: The temperature charts which I
have supplied have both shown an immediate response on the later oral 
administration of the sulphonsmide responsible for the original reaction.
Now such reasoning might seem to rest upon somewhat slender 
evidence. But recently, Rich (1942) and Rich and Gregory (1943) have
produced pathological evidence vMch supports a belief in the 
similarity between the two conditions. Rich reported the autopsy 
findings in seven patients who died from serum disease or after the
administration of sulphonamides. Five of the cases had received 
serum with, in addition, sulphapyridine, sulphathiazole or /
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or sulphadiazine; one had received serum alone; and one had received 
sulphathiazole alone. The microscopic picture in a ll was the same, 
namely, an acute arteritis and peri-arteritis which involved the 
smaller vessels of a large variety of organs. Rich stated that 
the picture was essentially that of a periarteritis nodosa. Similar 
lesions were thus noted in those who had received both serum and 
drug, (b) the patient who had received serum alone and (c) the 
patient who had received sulphathiazole alone; i t  seems reasonable to 
suppose that there is  a relationship between the two toxic effects.
In their later paper, Rich and Gregory reported that they had been 
able to reproduce essentially similar lesions in rabbits. Finally, 
Lyons and Balberor (1942) have reported that 19 out of 53 patients 
who were given two or more courses of sulphathiazole showed an 
immediate response in the shape of fever or rash. Clearly, therefore, 
there is  a form of acute reaction to the drugs which may arise 
from previous sensitisation. The avoidance of drug fever and drug 
rashes is  therefore of some importance since i t  may vitiate  
la ter treatment.
That these reactions may be specific for the drug administered is  
shown by the following experience, reported by one of my resident
medical staff (Smith, 1944).
"At one time in the hospital a number of adult female patients 
were receiving in high dosage one of the sulphonamide series, namely, 
sulphaguanidLne. Of these, twenty developed a drug rash, often with 
some fever. Later four groups of three volunteers in each were given 
a single 1.0 g. dose of (a) sulphanilamide, (b) sulphapyridine, (c) /
-  281 -
(c) sulphathiazole snd (d) sulphaguenidlne. Only those who were 
given sulphaguenidlne shov/ed an immediate reaction by the development 
of a rash. Later s t i l l ,  the nine g irls who had failed to respond 
to the single dose of the other sulphonamides were each given a 
single dose of sulphaguenidlne. Seven of than developed an acute 
reaction with widespread rash, fever and sickness.”
Such an experience certainly emphasises the marked specificity 
of the reaction which is  again in keeping with the experience of 
serum disease. Sensitisation to chemicals is , of course, not new, 
for Landsteiner and Jacobs (1936) have reported the sensitisation 
of guinea-pigs to arsphenamine end neo-arsphenamine so that 
anaphylactic shock followed their intravenous injection.
Attention might be drawn to one further parallelism between 
the two conditions. Weaver (1909) drew attention to the fact 
th8t the occurrence of serum disease was related to the amount of 
foreign serum administered: the reaction.was more likely to develop
in those who received the larger amounts. A greater tendency for 
the development of drug rashes or drug fever in those who receive 
excessive or prolonged dosage of the sulphonsmides is  certainly 
suggested from the experience with sulphaguanidine reported above; 
nearly 50 per cent, of those who were given an excessive dose of the 
drug developed fever or rash. I have already indicated that the 
slightly lower incidence with sulphapyridine may be due to the 
shorter duration of treatment in pneumonia compared with erysipelas. 
Finally, I have shown that with excessive dosage of the drugs in the 
treatment of erysipelas the primary pyrexia was prolonged.
All /
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All of these experiences point to a similarity between the
two conditions — "serum disease” and sulphonamide rash or fever.
The question remains — to what is  the patient sensitised?
%
In the firs t  place, sensitisation is  unlikely to be due to
the common factor to a ll the drugs, namely, the sulphonamide radicle:
for were this the case the reaction would not be drug-specific.
(Sulphanilamide its e lf  may, of course, induce its  own specific
sensitisation). I t  might be thought that the allergy was induced
by each particular chemical. But, against this deduction can be
brought the fact that skin tests (using lin t  soaked in the drug
strapped to the skin by adhesive, plaster) have always, in my
experience, failed to produce a local reaction. Such evidence
is  not absolute, for i t  might well be necessary for the antigen
to be absorbed enterally . A third possibility may be advanced.
It  i s  possible that after absorption, the drugs combine with proteins
in the blood; and that these protein complexes are the offending
anephylectogens. Two recent reports tend to support such a view.
Gerber and Gross (1944) have recently shorn that sulphonsmide protein
conjugates can be prepared which produce a specific allergy; in
guinea-pigs demonstrated by the occurrence of anaphylaxis; and in
rabbits by the Schwarzman phenomenon. More recently, LeftwLch (1944)
has devised a test for sensitisation. The serum of persons ?/ho
have been receiving a sulphonamide drug for five to seven days without
i l l -e f fe c t  is  used for performing an intradermal test. The injection
of 0.05  c. cmm. causes a wheal which, develops to a maximum in about
fifteen to twenty minutes in persons who are sensitised to the drug. 
The injection of the drug alone, or of the individuals serum after /
after sulphonamide has disappeared from the blood, produces no
result. Such evidence strongly supports the view that the etiological
♦
agent is  a sulphonamide conjugate.
The importance of such a form of toxic effect should not he
exaggerated. The incidence figures reported here do not indicate
\
that they occur with great frequency. Nevertheless their occurrence 
and the possible mechanism of their causation deserve some emphasis; 
more especially i f  i t  is  true, as I have suggested, that they are 
likely  to occur more frequently when the period of treatment is  
prolonged. Such a finding may point a way to their avoidance.
From the evidence produced, therefore, ,it can be concluded 
that the drugs are of surprisingly low toxicity in the dosage 
usually given to man; especially when i t  is  remembered how much 
they contribute to the more effective clinical control, not only 
of the infections described in the preceding volumes, but of other 
such important diseases as meningococcal meningitis and gonorrhoea.,
This low incidence of serious side-effects is  combined with an ease 
of administration which should permit optimum benefit to follow 
their use, even in comparatively inexpert hands. I t  is  unfortunate 
that the toxicity of the drugs has often been exaggerated by the 
reports of isolated and serious effects from their use. For i t  has
occasioned their timorous application in general practice, where they 
can, in fact, be given as effectively as in hospital. I t  might indeed 
be said that no great skill is  required for their administration; 
the sk ill required lie s  in making the correct diagnosis of the diseases
in which they are known to exert a beneficial effect; and, more 
particularly, in realising when their administration should be stopped.
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